• Skip to main content
  • Skip to primary sidebar

Experienced Indiana Law Firm | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad, LLP | Trial Lawyers Giving Power to Your Voice for Over 55 Years

CohenMalad is rated highly on Google Reviews by clients.
Toll Free866.446.7478Toll Free317.636.6481
Make a Payment free consult
  • English
  • Español

Search

  • About Us
  • Attorneys
  • Services
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    • Español

Home » Lawsuits Move Forward for Patients Injured by HIV Drugs

Lawsuits Move Forward for Patients Injured by HIV Drugs

On June 14, 2022, California State Court Judge Andrew Y.S. Cheng denied a motion for summary judgment by Gilead Sciences effectively clearing a path to justice for patients injured by certain TDF-based drugs made by Gilead to treat HIV, for the prevention of HIV transmission (PrEP) and treatment for Hepatitis. This decision involves thousands of lawsuits in a Judicial Council Coordination Proceeding (JCCP) in the California Superior Court for San Francisco County.

Lawsuits filed by injured patients claim Gilead Sciences knowingly withheld a safer drug alternative to TDF-based drugs Truvada, Atripla, Stribild, Complera and Viread from the market to maximize profits. Patients prescribed those antiretroviral drugs suffered serious personal injuries including chronic kidney disease, renal failure, bone loss- including tooth loss, softening of the bones and severe bone fractures. This recent decision allows claims to move forward through courts.

CohenMalad, LLP attorneys are representing people who were prescribed Truvada, Atripla, Stribild, Complera or Viread and suffered serious injuries. “This is a major win for plaintiffs and a huge step forward in obtaining justice for those harmed by Gilead’s conduct,” stated partner Ned Mulligan who serves on the Plaintiffs’ Steering Committee and is the Co-Chair of Discovery.

CohenMalad, LLP attorneys have built a reputation as tough opponents in the courtroom and have a depth of experience in litigating claims for people who have been injured by dangerous drugs and medical devices. Contact us for a free case evaluation if you were prescribed TDF-based drugs manufactured by Gilead Sciences including Truvada, Atripla, Stribild, Viread or Complera and suffered a serious injury.

Primary Sidebar

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

ASK ABOUT AN INITIAL FREE CONSULTATION TODAY

  • Hidden
  • Hidden
  • This field is for validation purposes and should be left unchanged.

CohenMalad, LLP

One Indiana Square Suite 1400
Indianapolis, Indiana 46204
317.636.6481
Toll Free: 866.446.7478
  • twitter logo

Copyright © 2025 CohenMalad, LLP
Disclaimer Privacy Policy

  • About Us
  • Attorneys
  • Services
    ▼
    • Appellate Law
    • Business Services & Litigation
    • Class Action
    • Eminent Domain
    • Family Law
    • Medical Malpractice
    • Personal Injury
    • Pharmaceutical & Medical Device Litigation
    • Real Estate Services & Litigation
    • Sexual Abuse
  • Testimonials
  • Resources
    ▼
    • Alerts
    • Firm News
    • Video Library
    • Blog
    • FAQs
  • Contact
  • English
    ▼
    • Español
Cookies and other technology are used on this website to tailor your user experience and evaluate our marketing strategy. By clicking any link on this site you agree to our privacy policy.
En este sitio web utilizamos cookies y otras tecnologías para personalizar su experiencia de usuario y evaluar nuestra estrategia de marketing. Al hacer clic en cualquier enlace de esta plataforma, usted acepta nuestra política de privacidad.
Agree